Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
D000328:Adult; D000368:Aged; D001786:Blood Glucose; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000628:therapy; D005260:Female; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000008:administration & dosage* / Q000032:analysis / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010529:Peritoneal Cavity / Q000032:analysis*; D010530:Peritoneal Dialysis; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D010538:Peritonitis / Q000209:etiology
D001786:Blood Glucose; D007328:Insulin; D005947:Glucose